Related references
Note: Only part of the references are listed.Protective role of IL-33/ST2 axis in Con A-induced hepatitis
Vladislav Volarevic et al.
JOURNAL OF HEPATOLOGY (2012)
Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain
Melanie Pichery et al.
JOURNAL OF IMMUNOLOGY (2012)
NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis
Muhammad I. Arshad et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Interleukin-33: a novel mediator with a role in distinct disease pathologies
M. Kurowska-Stolarska et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1
Ana-Cristina Dragomir et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Nuclear expression of interleukin-33 in pancreatic stellate cells
Atsushi Masamune et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Role of interleukin 33 in human immunopathology
G. E. J. Murphy et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
Pierrick Marvie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Up-Regulation of Interleukin 33 and Soluble ST2 Serum Levels in Liver Failure
Georg A. Roth et al.
JOURNAL OF SURGICAL RESEARCH (2010)
IL-33 is a crucial amplifier of innate rather than acquired immunity
Keisuke Oboki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Strength of the Fas Ligand Signal Determines Whether Hepatocytes Act as Type 1 or Type 2 Cells in Murine Livers
Sven Schuengel et al.
HEPATOLOGY (2009)
Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage
Naiara Beraza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Interleukin-33-cytokine of dual function or novel alarmin?
Guttorm Haraldsen et al.
TRENDS IN IMMUNOLOGY (2009)
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Axel M. Kuchler et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
IL-33 is a chemoattractant for human Th2 cells
Mousa Komai-Koma et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis
P Van Lint et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality
A Wullaert et al.
HEPATOLOGY (2005)
Critical roles of TRAIL in hepatic cell death and hepatic inflammation
SJ Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms
S Haga et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity
H Higuchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL
K Kovalovich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TNF-α-induced expression of adhesion molecules in the liver is under the control of TNFR1 -: Relevance for concanavalin A-induced hepatitis
D Wolf et al.
JOURNAL OF IMMUNOLOGY (2001)
Importance of Kupffer cells for T-cell-dependent liver injury in mice
J Schümann et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Critical contribution of liver natural killer T cells to a murine model of hepatitis
K Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Essential pathogenetic role for interferon (IFN-)γ in concanavalin A-induced T cell-dependent hepatitis:: Exacerbation by exogenous IFN-γ and prevention by IFN-γ receptor-immunoglobulin fusion protein
F Nicoletti et al.
CYTOKINE (2000)
Share Paper
